首页|CCL28在哮喘急性发作患者血清中的表达研究

CCL28在哮喘急性发作患者血清中的表达研究

扫码查看
目的 探究CC趋化因子配体 28(CCL28)在哮喘急性发作患者血清中的表达意义.方法 选取2022年5月至2023年5月南京市雨花医院收治的哮喘急性发作患者50例为研究对象,选取同期本院门诊随访复查的哮喘缓解期患者50例为缓解组,健康体检者50名为对照组,比较三组CCL28水平的差异,通过ROC曲线评估CCL28水平诊断哮喘急性发作价值;比较急性发作哮喘患者不同严重程度CCL28水平与肺功能指标的差异,分析CCL28水平、肺功能指标与急性发作哮喘严重程度的相关性,CCL28水平与肺功能指标的相关性.结果 急性发作期CCL28水平>缓解期>对照组,差异有统计学意义(F=2 515.910,P<0.05).采用ROC分析血清CCL28水平诊断急性发作期哮喘的AUC、敏感度、特异度,AUC分别为0.884,敏感度、特异度分别为82.0%、88.0%.CCL28水平重度组>中度组>轻度组,差异有统计学意义(F=27.104,P<0.05),PEF、FEV1、FEV1/FVC水平比较:重度组<中度组<轻度组,差异有统计学意义(F=49.112、58.305、50.403,P<0.05).Person相关性分析显示,血清CCL28与急性发作期哮喘严重程度呈正相关(r=0.731,P<0.05),PEF、FEV1、FEV1/FVC与急性发作期哮喘严重程度呈负相关(r=-0.822、-0.843、-0.826,P<0.05).Person相关性分析显示,血清CCL28与PEF、FEV1、FEV1/FVC呈负相关(r=-0.847、-0.890、-0.821,P<0.05).结论 CCL28在哮喘急性发作患者血清中高表达,有望作为临床诊断哮喘急性发作的标志物,且与哮喘急性发作严重程度、肺功能指标相关密切.
Study on the expression of CCL 28 in serum of patients with acute asthma attacks
Objective To explore the significance of CC chemokine ligand 28(CCL 28)in the serum of patients with acute asthma attacks.Methods Fifty patients with an asthma attack admitted to our hospital from May 2022 to May 2023 were selected as the study subjects.50 patients with asthma in remission who were followed up and reviewed in our outpatient clinic during the same period were chosen as the remis-sion group.A control group of 50 healthy individuals who underwent medical checkups was also selected.The study aimed to compare the differences in CCL28 levels among the three groups to evaluate the diagnostic val-ue of CCL28 levels in identifying acute asthma attacks using ROC curves.Furthermore,the study compared the differences in CCL28 levels and lung function indexes among patients with different degrees of acute asth-ma attack severity.The analysis also included examining the correlation between CCL28 levels,lung function indexes,and the severity of acute asthma exacerbation,as well as the correlation between CCL28 levels and lung function indexes.Results The CCL28 level in acute exacerbation was greater than in remission and the control group,with a statistically significant difference(F=2 515.910,P<0.05).The AUC,sensitivity and specificity of serum CCL28 level for diagnosing asthma in acute exacerbation were analyzed by ROC,result-ing in an AUC of 0.884,sensitivity of 82.0%,and specificity of 88.0%.The CCL28 level was highest in the severe group,followed by the moderate group,and then the mild group,with a statistically significant differ-ence(F=27.104,P<0.05).The PEF,FEV1,and FEV1/FVC ratio were lower in the severe group compared to the moderate and mild groups,with statistically significant difference(F=49.112,58.305,50.403,P<0.05).Person correlation analysis showed that serum CCL28 levels were positively correlated with the severity of acute exacerbation asthma(r=0.731,P<0.05),while PEF,FEV1,and FEV1/FVC ratio were negatively correlated with asthma severity(r=-0.822,-0.843,-0.826,P<0.05).Furthermore,serum CCL28 levels were negatively correlated with PEF,FEV1,and FEV1/FVC ratio(r=-0.847,-0.890,-0.821,P<0.05).Conclusion CCL28 is found in high levels in the serum of patients with acute asthma attacks.It is closely linked to the severity of acute asthma attacks and lung function indicators.

AsthmaAcute onsetCC chemokine ligand 28

晏远飞、王兆媛、刘景

展开 >

南京市雨花医院呼吸内科,江苏,南京21003

南京艾迪康医学检验所临床实验室,江苏,南京 211100

南京市雨花医院检验科,江苏,南京 210039

哮喘 急性发作 CC趋化因子配体28

南京市卫生科技发展专项

YKK23215

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(5)
  • 11